282,264 Shares in Clover Health Investments, Corp. (NASDAQ:CLOV) Purchased by Graham Capital Management L.P.

Graham Capital Management L.P. bought a new stake in shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 282,264 shares of the company's stock, valued at approximately $889,000. Graham Capital Management L.P. owned approximately 0.06% of Clover Health Investments at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Marshall Wace LLP raised its stake in Clover Health Investments by 167.6% in the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company's stock worth $11,875,000 after buying an additional 2,360,902 shares in the last quarter. Teacher Retirement System of Texas purchased a new position in Clover Health Investments in the fourth quarter valued at about $2,769,000. Schonfeld Strategic Advisors LLC bought a new position in Clover Health Investments in the fourth quarter worth about $1,860,000. American Century Companies Inc. lifted its position in Clover Health Investments by 181.0% during the fourth quarter. American Century Companies Inc. now owns 764,694 shares of the company's stock valued at $2,409,000 after acquiring an additional 492,527 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in Clover Health Investments by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company's stock worth $61,693,000 after purchasing an additional 386,499 shares during the last quarter. Hedge funds and other institutional investors own 19.77% of the company's stock.

Clover Health Investments Price Performance

CLOV stock traded up $0.02 during trading on Monday, hitting $3.57. The stock had a trading volume of 1,487,226 shares, compared to its average volume of 6,660,186. Clover Health Investments, Corp. has a twelve month low of $0.86 and a twelve month high of $4.87. The company's 50-day moving average price is $3.55 and its two-hundred day moving average price is $3.69. The stock has a market capitalization of $1.81 billion, a P/E ratio of -17.72 and a beta of 1.99.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.12. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. The business had revenue of $462.33 million during the quarter, compared to analyst estimates of $466.93 million. As a group, sell-side analysts expect that Clover Health Investments, Corp. will post -0.12 EPS for the current fiscal year.

Insider Activity at Clover Health Investments

In related news, General Counsel Karen Soares sold 52,500 shares of the business's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $3.80, for a total value of $199,500.00. Following the sale, the general counsel now owns 1,299,663 shares in the company, valued at approximately $4,938,719.40. The trade was a 3.88% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Brady Patrick Priest sold 75,000 shares of Clover Health Investments stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $3.68, for a total value of $276,000.00. Following the completion of the transaction, the chief executive officer now owns 2,418,151 shares of the company's stock, valued at approximately $8,898,795.68. This trade represents a 3.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 327,500 shares of company stock worth $1,197,500. Company insiders own 22.28% of the company's stock.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group lifted their price objective on shares of Clover Health Investments from $4.20 to $4.50 and gave the stock a "buy" rating in a research note on Monday, March 3rd.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.